| Cyclohexanecarboxylic acid, 4-(1,6-dihydro-4-methyl-6-oxo-2-pyrimidinyl)-1-methoxy-, methyl ester |
Cyclohexanecarboxylic acid, 4-(1,6-dihydro-4-methyl-6-oxo-2-pyrimidinyl)-1-methoxy-, methyl ester |
2097133-30-5 |
| 3-BROMO-6-METHYL-2-OXO-1(2H)-PYRAZINEACETIC ACID ETHYL ESTER |
2-(3-溴-6-甲基-2-吡嗪酮-1(2H)-基)乙酸乙酯 |
221136-66-9 |
| (3R,5R,8R,9R,10S,13S,14S)-3-hydroxy-3,13-dimethyltetradecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one(WX116161) |
(3R,5R,8R,9R,10S,13S,14S)-3-hydroxy-3,13-dimethyltetradecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one(WX116161) |
1632051-92-3 |
| 1634628-95-7 |
1634628-95-7 |
1634628-95-7 |
| (R)-4-((S)-1-fluoroethyl)oxazolidin-2-one |
(R)-4-((S)-1-fluoroethyl)oxazolidin-2-one |
1628810-07-0 |
| (S)-1-(5-bromo-4-methylpyridin-2-yl)ethanamine hydrochloride |
1628810-35-4 |
1628810-35-4 |
| Tofacitinib related coMpound 2 |
托法替尼相关化合物2 |
1629858-78-1 |
| Intermediate |
INTERMEDIATE |
1620740-65-9 |
| 2-(4-fluoro-2-methylphenoxy)-N-(2-oxo-1l4,2l5-pyridin-4-yl)-4-(trifluoromethyl)benzamide |
2-(4-氟-2-甲基苯氧基)-N-(2-氧代-1,2-二氢吡啶-4-基)-4-(三氟甲基)苯甲酰胺 |
1620846-16-3 |
| VT-464 |
CS-1247 |
1610537-15-9 |
| Cobimetinib intermediate2 |
COBIMETINIB中间体2 |
1597407-55-0 |
| (S)-methyl-6-bromo-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate |
1598387-95-1 |
1598387-95-1 |
| 1565736-85-7 |
1565736-85-7 |
1565736-85-7 |
| Methanone, [3-(3-amino-2,6-difluorobenzoyl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-1-yl](2,6-dichlorophenyl)- |
(3-(3-氨基-2,6-二氟苯甲酰基)-5-溴-1H-吡咯并[2,3-B]吡啶-1-基)(2,6- |
1501153-67-8 |
| 1492957-96-6 |
1492957-96-6 |
1492957-96-6 |
| 1449029-77-9 |
1449029-77-9 |
1449029-77-9 |
| 2-(oxazol-2-yl)-4-phenylthiazol-5-amine |
2-(恶唑-2-基)-4-苯基噻唑-5-胺 |
1446183-03-4 |
| (2R,3S,4S,5R)-2,3,4-tris(benzyloxy)-4-(4-(benzyloxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-(4-methylpiperazin-1-yl)butan-1-one |
1431329-05-3 |
1431329-05-3 |
| 1430836-75-1 |
1430836-75-1 |
1430836-75-1 |
| (S)-2,4-dichloro-1-(1,2-dichloroethyl)benzene |
(S)-2-氯-1-(2,4-二氯苯)-乙醇 |
1428650-20-7 |
